The Chemours Company (CC)
| Market Cap | 2.04B -1.1% |
| Revenue (ttm) | 5.80B -0.9% |
| Net Income | -304.00M |
| EPS | -2.03 |
| Shares Out | 150.50M |
| PE Ratio | n/a |
| Forward PE | 9.61 |
| Dividend | $0.35 (2.59%) |
| Ex-Dividend Date | Nov 16, 2026 |
| Volume | 2,159,806 |
| Open | 12.96 |
| Previous Close | 13.19 |
| Day's Range | 12.95 - 13.58 |
| 52-Week Range | 10.44 - 28.67 |
| Beta | 1.40 |
| Analysts | Hold |
| Price Target | 16.50 (+21.95%) |
| Earnings Date | Nov 2, 2026 |
About CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that del... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for CC stock is "Hold." The 12-month stock price target is $16.5, which is an increase of 21.95% from the latest price.
News
Kaplan Fox Encourages The Chemours Company (CC) Investors to Contact the Firm Before the Deadline on December 7, 2026 for a Leadership Role
New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (N...
CC Shareholders Have Rights – If You Lost Money Investing in The Chemours Company Contact Robbins LLP for Information About Recovering Your Losses
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquire...
Kaplan Fox Advises The Chemours Company (CC) Investors to Act Before the Lead Plaintiff Deadline on December 7, 2026
New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (N...
Chemours Announces Fourth Quarter Dividend
WILMINGTON, Del., Oct. 27, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per s...
Chemours Announces Dates for Third Quarter 2026 Earnings Release and Webcast Conference Call
WILMINGTON, Del., Oct. 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its third quarter 2026 financial results...
CC Loss Notice: Chemours Investors are Reminded of the December 7 Court Deadline – Contact BFA Law if You Lost Money
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and cert...
What Does The Chemours Company's 18.63% Stock Drop Mean for Investors? The Law Offices of Howard G.
Suit alleges The Chemours Company failed to disclose key facts to investors from February 20, 2026 through August 4, 2026; lead plaintiff deadline is December 7, 2026 BENSALEM TOWNSHIP, Pa., Oct. 20, ...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of December 7, 2026 in The Chemours Company Lawsuit - CC
Time-Sensitive: Allegations Focus on 2026 EBITDA Guidance Representations. The lawsuit asserts that Chemours reaffirmed a full-year outlook that allegedly ignored aftermarket prebuy activity, which pu...
Chemours price target lowered to $20 from $24 at Truist
Truist lowered the firm’s price target on Chemours (CC) to $20 from $24 and keeps a Buy rating on the shares as part of a broader research note previewing Q3…
What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R.
Lawsuit alleges The Chemours Company made misleading statements to investors from February 20, 2026 to August 4, 2026; lead plaintiff motions are due December 7, 2026 LOS ANGELES, Oct. 19, 2026 /PRNew...
Kaplan Fox Reminds The Chemours Company (CC) Investors with Significant Losses to Seek a Leadership Role Before Deadline on December 7, 2026
New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (N...
Chemours takes action to protect refrigerant technology intellectual property
Chemours (CC) announced that it has taken action to protect its intellectual property relating to refrigerant technology during Chillventa in Nuremberg, Germany. Local courts issued injunctions agains...
Chemours and Local Officials Take Action to Protect Refrigerant Intellectual Property at Chillventa
Action reflects Chemours' commitment to innovation, intellectual property protection, our customers, and fair competition in the refrigerants industry WILMINGTON, Del., Oct. 19, 2026 /PRNewswire/ -- T...
CC Deadline Reminder: Chemours Investors are Notified to Contact BFA Law before the Expiration of the December 7 Lead Plaintiff Deadline
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and cert...
Kaplan Fox Notifies Investors of The Chemours Company (CC) of the Lead Plaintiff Deadline on December 7, 2026
New York, New York--(Newsfile Corp. - October 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (N...
Chemours downgraded to Neutral from Outperform at Mizuho
Mizuho analyst John Roberts downgraded Chemours (CC) to Neutral from Outperform with a price target of $15, down from $18. The firm notes that its prior Outperform rating was based…
Chemours downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Chemours (CC) to Sector Perform from Outperform with a price target of $14, down from $22. The firm cites persistent TiO2 weakness despite cost reduction benefits for…
Chemours initiated with an Equal Weight at Barclays
Barclays initiated coverage of Chemours (CC) with an Equal Weight rating and $16 price target
Chemours price target lowered to $16 from $18 at UBS
UBS lowered the firm’s price target on Chemours (CC) to $16 from $18 and keeps a Neutral rating on the shares.
Chemours price target lowered to $18 from $20 at Mizuho
Mizuho analyst John Roberts lowered the firm’s price target on Chemours (CC) to $18 from $20 and keeps an Outperform rating on the shares. The firm says fundamental supply/demand for…
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…
Chemours, DuPont and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contam...